FLT3 antibody (AA 930-991)

Catalog No. ABIN1724846

The Mouse Monoclonal anti-FLT3 antibody has been validated for ELISA and IHC. It is suitable to detect FLT3 in samples from Human. There are 2+ publications available.

Quick Overview for FLT3 antibody (AA 930-991) (ABIN1724846)

Target: FLT3 (Fms-Related tyrosine Kinase 3 (FLT3))

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This FLT3 antibody is un-conjugated

Application: ELISA, Immunohistochemistry (IHC)

Clone: 7B7C3

Product Details anti-FLT3 Antibody

Binding Specificity: AA 930-991

Purpose: FLT3 Antibody

Purification: Purified antibody

Immunogen: Purified recombinant fragment of human FLT3 (AA: 930-991) expressed in E. Coli.

Isotype: IgG1

Application Details

Application Notes: ELISA: 1/10000

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Purified antibody in PBS with 0.05 % sodium azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C,-20 °C

Storage Comment: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.

References for anti-FLT3 antibody (ABIN1724846)

Pereira de Sousa, Berthault, Granato, Dias, Ramond, Kee, Cumano, Vieira: "Inhibitors of DNA binding proteins restrict T cell potential by repressing Notch1 expression in Flt3-negative common lymphoid progenitors." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 189, Issue 8, pp. 3822-30, (2012) (PubMed).

How, Sykes, Gupta, Yee, Schimmer, Schuh, Minden, Kamel-Reid, Brandwein: "Influence of FLT3-internal tandem duplication allele burden and white blood cell count on the outcome in patients with intermediate-risk karyotype acute myeloid leukemia." in: Cancer, Vol. 118, Issue 24, pp. 6110-7, (2012) (PubMed).

Target Details for FLT3

Target: FLT3 (Fms-Related tyrosine Kinase 3 (FLT3))

Alternative Name: FLT3

Background: This gene encodes a class III receptor tyrosine kinase that regulates hematopoiesis. The receptor consists of an extracellular domain composed of five immunoglobulin-like domains, one transmembrane region, and a cytoplasmic kinase domain split into two parts by a kinase-insert domain. The receptor is activated by binding of the fms-related tyrosine kinase 3 ligand to the extracellular domain, which induces homodimer formation in the plasma membrane leading to autophosphorylation of the receptor. The activated receptor kinase subsequently phosphorylates and activates multiple cytoplasmic effector molecules in pathways involved in apoptosis, proliferation, and differentiation of hematopoietic cells in bone marrow. Mutations that result in the constitutive activation of this receptor result in acute myeloid leukemia and acute lymphoblastic leukemia.

Molecular Weight: 130 kDa

Gene ID: 2322

UniProt: P36888

Pathways: RTK Signaling